BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32440014)

  • 1. Absence of damaging effects of stem cell donation in unrelated donors assessed by FISH and gene variance screening.
    Nacheva E; Ahyee T; Addada J; Navarette C; Pamphilon D; Regan F; Pawson R; Szydlo R; Goldman J; Mackinnon S; Shaw BE; Madrigal A
    Bone Marrow Transplant; 2020 Jul; 55(7):1290-1296. PubMed ID: 32440014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shorter Interdonation Interval Contributes to Lower Cell Counts in Subsequent Stem Cell Donations.
    Panch SR; Logan B; Sees JA; Bo-Subait S; Savani B; Shah NN; Hsu JW; Switzer G; Lazarus HM; Anderlini P; Hematti P; Confer D; Pulsipher MA; Shaw BE; Stroncek DF
    Transplant Cell Ther; 2021 Jun; 27(6):503.e1-503.e8. PubMed ID: 33823169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Pre-Apheresis Health Related Quality of Life on Peripheral Blood Progenitor Cell Yield and Donor's Health and Outcome: Secondary Analysis of Patient-Reported Outcome Data from the RDSafe and BMT CTN 0201 Clinical Trials.
    Farhadfar N; Ahn KW; Bo-Subait S; Logan B; Stefanski HE; Hsu JW; Panch S; Confer D; Liu H; Badawy SM; Beitinjaneh A; Diaz MA; Hildebrandt GC; Kelkar AH; Lazarus HM; Murthy HS; Preussler JM; Schears RM; Sharma A; van der Poel M; Bruce JG; Pulsipher MA; Shaw BE; Wingard JR; Switzer GE
    Transplant Cell Ther; 2022 Sep; 28(9):603.e1-603.e7. PubMed ID: 35688325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Safety of Short-Term Administration of Filgrastim (rhG-CSF) and Leukophresis Procedure in Healthy Children: Application of Peripheral Blood Stem Cell Collection in Pediatric Donors.
    Behfar M; Faghihi-Kashani S; Hosseini AS; Ghavamzadeh A; Hamidieh AA
    Biol Blood Marrow Transplant; 2018 Apr; 24(4):866-870. PubMed ID: 29284143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower platelet count with increased density of platelet antigens in granulocyte colony-stimulating factor mobilized peripheral blood stem cell donors.
    Wu YF; Gu MH; Yang SH; Wang TF
    J Formos Med Assoc; 2020 Jan; 119(1 Pt 2):204-210. PubMed ID: 31003920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of granulocyte-colony stimulating factor on chromosome aneuploidy and replication asynchrony in healthy peripheral blood stem cell donors.
    Hirsch B; Oseth L; Cain M; Trader E; Pulkrabek S; Lindgren B; Luo X; Clay M; Miller J; Confer D; Weisdorf D; McCullough J
    Blood; 2011 Sep; 118(9):2602-8. PubMed ID: 21719598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recovery of Unrelated Donors of Peripheral Blood Stem Cells versus Recovery of Unrelated Donors of Bone Marrow: A Prespecified Analysis from the Phase III Blood and Marrow Transplant Clinical Trials Network Protocol 0201.
    Burns LJ; Logan BR; Chitphakdithai P; Miller JP; Drexler R; Spellman S; Switzer GE; Wingard JR; Anasetti C; Confer DL;
    Biol Blood Marrow Transplant; 2016 Jun; 22(6):1108-1116. PubMed ID: 27013014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow harvest versus peripheral stem cell collection for haemopoietic stem cell donation in healthy donors.
    Siddiq S; Pamphilon D; Brunskill S; Doree C; Hyde C; Stanworth S
    Cochrane Database Syst Rev; 2009 Jan; (1):CD006406. PubMed ID: 19160282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower risk for serious adverse events and no increased risk for cancer after PBSC vs BM donation.
    Pulsipher MA; Chitphakdithai P; Logan BR; Navarro WH; Levine JE; Miller JP; Shaw BE; O'Donnell PV; Majhail NS; Confer DL
    Blood; 2014 Jun; 123(23):3655-63. PubMed ID: 24735965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-related quality of life of bone marrow versus peripheral blood stem cell donors: a prespecified subgroup analysis from a phase III RCT-BMTCTN protocol 0201.
    Switzer GE; Bruce JG; Harrington D; Haagenson M; Drexler R; Foley A; Confer D; Bishop M; Anderlini P; Rowley S; Leitman SF; Anasetti C; Wingard JR
    Biol Blood Marrow Transplant; 2014 Jan; 20(1):118-27. PubMed ID: 24184336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Safety comparison of mobilization and collection of hematopoietic stem cells between related and unrelated donors].
    Zhang S; Jin H; Xu LP; Liu DH; Chen H; Liang YQ; Li T; Li FX; Wang R; Kang Q; Chen YH; Zhang XH; Han W; Huang XJ; Liu KY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):1017-22. PubMed ID: 20723320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term side effects and attitudes towards second donation: A comparison of related and unrelated haematopoietic stem cell donors.
    Pahnke S; Larfors G; Axdorph-Nygell U; Fischer-Nielsen A; Haastrup E; Heldal D; Itälä-Remes M; Johansson JE; Kauppila M; Lenhoff S; Ljungman P; Niittyvuopio R; Sandstedt A; Hägglund H
    J Clin Apher; 2018 Jun; 33(3):226-235. PubMed ID: 28833474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor Experiences of Second Marrow or Peripheral Blood Stem Cell Collection Mirror the First, but CD34
    Stroncek DF; Shaw BE; Logan BR; Kiefer DM; Savani BN; Anderlini P; Bredeson CN; Hematti P; Ganguly S; Diaz MA; Abdel-Azim H; Ahmed I; Maharaj D; Seftel M; Beitinjaneh A; Seo S; Yared JA; Halter J; O'Donnell PV; Hale GA; DeFilipp Z; Lazarus H; Liesveld JL; Zhou Z; Munshi P; Olsson RF; Kasow KA; Szer J; Switzer GE; Chitphakdithai P; Shah N; Confer DL; Pulsipher MA
    Biol Blood Marrow Transplant; 2018 Jan; 24(1):175-184. PubMed ID: 28958894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte colony-stimulating factor-induced mobilization of peripheral blood stem cells for autologous and allogeneic transplantation. Fukuoka Bone Marrow Transplantation Group.
    Harada M; Teshima T; Fujisaki T; Mizuno S; Miyamoto T; Takamatsu Y; Kubota A; Ohno Y; Kuroiwa M; Takenaka K; Eto T; Akashi K; Gondo H; Okamura T; Inaba S; Niho Y
    Cancer Chemother Pharmacol; 1996; 38 Suppl():S115-9. PubMed ID: 8765430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective Analysis of 37,287 Observation Years after Peripheral Blood Stem Cell Donation.
    Schmidt AH; Mengling T; Hernández-Frederick CJ; Rall G; Pingel J; Schetelig J; Ehninger G
    Biol Blood Marrow Transplant; 2017 Jun; 23(6):1011-1020. PubMed ID: 28254417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe short-term adverse events in related bone marrow or peripheral blood stem cell donors.
    Yanagisawa R; Hirakawa T; Doki N; Ikegame K; Matsuoka KI; Fukuda T; Nakamae H; Ota S; Hiramoto N; Ishikawa J; Ara T; Tanaka M; Koga Y; Kawakita T; Maruyama Y; Kanda Y; Hino M; Atsuta Y; Yabe H; Tsukada N
    Int J Hematol; 2023 Mar; 117(3):421-427. PubMed ID: 36403180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with granulocyte colony-stimulating factor-induced peripheral blood stem cell yield in healthy donors.
    Suzuya H; Watanabe T; Nakagawa R; Watanabe H; Okamoto Y; Onishi T; Abe T; Kawano Y; Kagami S; Takaue Y
    Vox Sang; 2005 Nov; 89(4):229-35. PubMed ID: 16262756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donating stimulated peripheral blood stem cells vs bone marrow: do donors experience the procedures differently?
    Switzer GE; Goycoolea JM; Dew MA; Graeff EC; Hegland J
    Bone Marrow Transplant; 2001 May; 27(9):917-23. PubMed ID: 11436101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceptance and feasibility of peripheral stem cell mobilisation compared to bone marrow collection from healthy unrelated donors.
    Ordemann R; Hölig K; Wagner K; Rautenberg U; Bornhäuser M; Kroschinsky F; Schäfer J; Schuler U; Ehninger G
    Bone Marrow Transplant; 1998 Jun; 21 Suppl 3():S25-8. PubMed ID: 9712488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.